HAIKOU CITY, China, March 1 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it will participate in the following conferences:
-- Rodman & Renshaw Annual China Investment Conference, to be held
March 7-9, 2010 at the Regent hotel in Beijing, China. Management is
scheduled to present at 4:05 pm local time on Monday, March 8, and meet
with institutional investors throughout the conference.
-- Cowen & Company’s 30th Annual Health Care Conference, to be held March
8-11 at the Marriott Copley Place in Boston. Management is scheduled
to present at 8:45 am local time on Wednesday, March 10, and meet with
institutional investors throughout the conference.
-- Roth 22nd Annual OC Growth Stock Conference, to be held March 15-17,
2010 at the Ritz Carlton hotel in Dana Point, CA. Management is
scheduled to present at 9:00 am local time on Tuesday, March 16, and
meet with institutional investors throughout the conference.
For further details, please contact your respective institutional sales representative.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company’s cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .
For more information, please contact:
China Pharma Holdings, Inc.
Tel: +86-898-6681-1730
Email: hps@chinapharmaholdings.com
ICR, Inc.
Christine Duan
Tel: +1-203-682-8200
